Myozyme

 

Topic mentions per year

Topic mentions per year

2006-2018
024620062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Purpose:High sustained antibody titers complicate many disorders treated with a therapeutic protein, including those treated with… (More)
  • figure 1
Is this relevant?
2011
2011
OBJECTIVE Pompe disease is an autosomal recessive lysosomal disorder caused by α-glucosidase deficiency. A specific treatment for… (More)
  • table 2
Is this relevant?
2010
2009
2009
To the Editor: Infantile Pompe’s disease is due to a deficiency of lysosomal acid alpha glucosidase (GAA). In patients in whom… (More)
  • figure 1
Is this relevant?
2009
2009
BACKGROUND Pompe disease (Glycogen storage disorder type II) is an inherited disease because of a lack or reduced activity of the… (More)
  • table 1
  • table 2
Is this relevant?
Review
2009
Review
2009
Pompe disease is a rare autosomal recessive lysosomal storage disease caused by deficiency of acid-a-glucosidase (GAA). This… (More)
Is this relevant?
2008
2008
Benefits of enzyme replacement therapy with Myozyme (alglucosidase alfa), anecdotally reported in late-onset Pompe disease, range… (More)
Is this relevant?
2008
2008
Pompe disease results in the accumulation of lysosomal glycogen in multiple tissues due to a deficiency of acid alpha-glucosidase… (More)
Is this relevant?
2007
2007
BACKGROUND Pompe's disease, a rare, inherited deficiency of the enzyme alpha-1,4-glucosidase (GAA), is a lysosomal storage… (More)
Is this relevant?
2007
2007
Glycogen storage disease in the alpha-glucosidase knockout(6neo(-)/6neo(-)) (GAA KO) mouse, a model of Pompe disease, results in… (More)
Is this relevant?